Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling

Nature Reviews Immunology

Volumn 14, Issue 2, 2014, Pages 69-80

  Clark, Marcus R ^a   Mandal, Malay ^a   Ochiai, Kyoko ^b   Singh, Harinder ^c,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GENENTECH INC   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN D3; INTERLEUKIN 7 RECEPTOR; JANUS KINASE 3; PRE B CELL RECEPTOR; STAT5 PROTEIN;

CELL SELECTION; GENETIC RECOMBINATION; GENOMICS; HUMAN; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SURVIVAL FACTOR;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CYCLIN D2; CYCLIN D3; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOPOIESIS; PHOSPHATIDYLINOSITOL 3-KINASES; PRE-B CELL RECEPTORS; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84893685103     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3570     Document Type: Review

References (153)

1. Schlissel, M. S. Regulating antigen-receptor gene assembly. Nature Rev. Immunol. 3, 890-899 (2003).
2. Clark, M. R., Cooper, A. B., Wang, L. and Aifantis, I. The pre-B cell receptor in B cell development: recent advances, persistent questions and conserved mechanisms. Curr. Top. Microbiol. Immunol. 290, 87-104 (2005).
3. Herzog, S., Reth, M. and Jumaa, H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signaling. Nature Rev. Immunol. 9, 195-205 (2009).
4. Zhang, L., Reynolds, T. L., Shan, S. and Desiderio, S. Coupling of V(D)J recombination to cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity 34, 163-174 (2011).
5. Corfe, S. A. and Paige, C. J. The many roles of IL-7 in B cell development; Mediator of survival, proliferation and differentiation. Semin. Immunol. 24, 198-208 (2012).
6. Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960 (1994).
7. Jensen, C. T. et al. FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. Blood 112, 2297-2304 (2008).
8. Clark, M. R. Flippin' lipids. Nature Immunol. 12, 373-375 (2011).
9. Siggs, O. M. et al. The P4 ATPase ATP11c is essential for B lymphopoiesis in adult bone marrow. Nature Immunol. 12, 434-440 (2011).
10. Yabas, M. et al. ATP11c is critical for phosphatidylserine internalization and B lymphocyte differentiation. Nature Immunol. 12, 441-449 (2011).
11. Puel, A., Ziegler, S. F., Buckley, R. H. and Leonard, W. J. Defective IL7R expression in T-B+ NK+ severe combined immunodeficiency. Nature Genet. 20, 394-397 (1998).
12. Giliani, S. et al. Interleukin-7 receptor α (IL-7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol. Rev. 203, 110-126 (2005).
13. O'Shea, J. J. and Plenge, R. M. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542-550 (2012).
14. Chou, W. C., Levy, D. E. and Lee, C. K. STAT3 positively regulates an early step in B-cell development. Blood 108, 3005-3011 (2006).
15. Yao, Z. et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc. Natl Acad. Sci. USA 103, 1000-1005 (2006).
16. Goetz, C. A., Harmon, I. R., O'Neil, J. J., Burchill, M. A. and Farrar, M. A. STAT5 activation underlies IL7 receptor-dependent B cell development. J. Immunol. 172, 4770-4778 (2004).
17. Mandal, M. et al. Ras orchestrates cell cycle exit and light chain recombination during early B cell development. Nature Immunol. 10, 1110-1117 (2009).
18. Johnson, S. E., Shah, N., Panoskaltsis-Mortari, A. and LeBien, T. W. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J. Immunol. 175, 7325-7331 (2005).
19. Cooper, A. B. et al. A unique function for cyclin D3 in early B cell development. Nature Immunol. 7, 489-497 (2006).
20. Sherr, C. J. and Roberts, J. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
21. Ciemerych, M. A. and Sicinski, P. Cell cycle in mouse development. Oncogene 24, 2877-2898 (2005).
22. Kozar, K. et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477-491 (2004).
23. Malumbres, M. et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118, 493-504 (2004).
24. Powers, S. E. et al. Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression. J. Exp. Med. 209, 2199-2213 (2012).
25. Sicinska, E. et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4, 451-461 (2003).
26. Peled, J. U. et al. Requirement for cyclin D3 in germinal center formation and function. Cell Res. 20, 631-646 (2010).
27. Lam, E. W. et al. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J. Biol. Chem. 275, 3479-3484 (2000).
28. Solvason, N. et al. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 12, 631-638 (2000).
29. Johnson, K. et al. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28, 335-345 (2008).
30. Ma, S. et al. Ikaros and Aiolos inhibit pre-B cell proliferation by directly suppressing c-Myc expression. Mol. Cell. Biol. 30, 4149-4158 (2010).
31. Nakayama, K. et al. Mice lacking p27kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 85, 707-720 (1996).
32. Malin, S. et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nature Immunol. 11, 171-179 (2010).
33. Jiang, Q. et al. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol. Cell. Biol. 24, 6501-6513 (2004).
34. Bednarski, J. J. et al. RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation. J. Exp. Med. 209, 11-17 (2011).
35. Milne, C. D. and Paige, C. J. IL-7: a key regulator of B lymphopoiesis. Semin. Immunol. 18, 20-30 (2006).
36. Ochiai, K. et al. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nature Immunol. 13, 300-307 (2012).
37. Corcoran, A. E. et al. The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15, 1924-1932 (1996).
38. Ramadani, F. et al. The PI3K isoforms p110α and p110δ are essential for pre-B cell receptor signaling and B cell development. Sci. Signal. 3, ra60 (2010).
39. Fruman, D. A. et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999).
40. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3- kinase. Science. 283, 390-392 (1999).
41. Clayton, E. et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196, 753-763 (2002).
42. Jou, S.-T. et al. Essential, nonredundant role of the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22, 8580-8591 (2002).
43. Okkenhaug, K. et al. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297, 1031-1034 (2002).
44. Huntington, N. D. et al. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7. Int. Immunol. 21, 715-725 (2009).
45. Kruse, E. A. et al. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. J. Immunol. 183, 261-269 (2009).
46. Danial, N. N. and Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205-219 (2004).
47. Essafi, A. et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24, 2317-2329 (2005).
48. Castellano, E. and Downward, J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2, 261-274 (2011).
49. Lin, H. and Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995).
50. Medina, K. L. et al. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7, 607-617 (2004).
51. Pongubala, J. M. et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nature Immunol. 9, 203-215 (2008).
52. Singh, H., Medina, K. L. and Pongubala, M. R. Contigent gene regulatory networks and B cell fate specification. Proc. Natl Acad. Sci. USA 102, 4949-4953 (2005).
53. Nutt, S. L. and Kee, B. L. The transcriptional regulation of B cell lineage commitment. Immunity 26, 715-725 (2007).
54. Gyory, I. et al. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev. 26, 668-682 (2012).
55. Dengler, H. S. et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nature Immunol. 12, 1388-1398 (2008).
56. Fahlman, C., Blomhoff, H. K., Veiby, O. P., McNiece, I. K. and Jacobsen, S. E. Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood 84, 1450-1456 (1994).
57. Fahl, S. P., Crittenden, R. B., Allman, D. and Bender, T. P. c-Myb is required for pro-B cell differentiation. J. Immunol. 183, 5582-5592 (2009).
58. Kosan, C. et al. Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 33, 917-928 (2010).
59. Hardin, J. D. et al. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165, 44-54 (1995).
60. Schwartzberg, P. L. et al. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175 (1991).
61. Tybulewicz, V. L., Crawford, C. E., Jackson, P. K., Bronson, R. T. and Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-Abl proto-oncogene. Cell 65, 1153-1164 (1991).
62. Brightbill, H. and Schlissel, M. S. The effects of c-Abl mutation on developing B cell differentiation and survival. Int. Immunol. 21, 575-585 (2009).
63. Lam, Q. L. et al. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice. Int. Immunol. 19, 267-276 (2007).
64. Gu, J. J., Zhang, N., He, Y. W., Koleske, A. J. and Pendergast, A. M. Defective T cell development and function in the absence of Abelson kinases. J. Immunol. 179, 7334-7344 (2007).
65. Zipfel, P. A. et al. The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J. Immunol. 165, 6872-6881 (2000).
66. Roose, J. P. et al. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biol. 1, E53 (2003).
67. Kharbanda, S. et al. Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents. Nature 376, 785-788 (2002).
68. Kondo, M., Akashi, K., Domen, J., Sugamura, K. and Weissman, I. L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity 7, 155-162 (1997).
69. Roessler, S. et al. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol. Cell. Biol. 27, 579-594 (2007).
70. Dias, S., Mansson, R., Gurbuxani, S., Sigvardsson, M. and Kee, B. L. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29, 217-227 (2005).
71. Kikuchi, K., Lai, A. Y., Hsu, C. L. and Kondo, M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201, 1197-1203 (2005).
72. Rothenberg, E. V., Moore, J. E. and Yui, M. A. Launching the T-cell-lineage developmental programme. Nature Rev. Immunol. 8, 9-21 (2008).
73. Herzog, S. et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3) K-PKB-Foxo pathway. Nature Immunol. 9, 623-631 (2008).
74. Amin, R. H. and Schlissel, M. S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nature Immunol. 9, 613-622 (2008).
75. Lee, J. and Desiderio, S. Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity 11, 771-781 (1999).
76. Li, Z., Dordai, D. I., Lee, J. and Desiderio, S. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 5, 575-589 (1996).
77. Jiang, H. et al. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol. Cell 18, 699-709 (2005).
78. Johnson, K. et al. IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle. J. Immunol. 188, 6084-6092 (2012).
79. Reynaud, D. et al. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nature Immunol. 9, 927-936 (2008).
80. Alkhatib, A. et al. FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination. J. Exp. Med. 209, 395-406 (2012).
81. Bertolino, E. et al. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nature Immunol. 6, 836-843 (2005).
82. Kitamura, D., Roes, J., Kuhn, R. and Rajewsky, K. A. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426 (1991).
83. Shimizu, T., Mundt, C., Licence, S., Melchers, F. and Martensson, I. VpreB1/VpreB2/λ5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J. Immunol. 168, 6286-6293 (2002).
84. Pelanda, R., Braun, U., Hobeika, E., Nussenzweig, M. C. and Reth, M. B cell progenitors are arrested in maturation but have intact V(D)J recombination in the absence of Ig-α and Ig-β. J. Immunol. 169, 865-872 (2002).
85. Gong, S. and Nussenzweig, M. C. Regulation of an early developmental checkpoint in the B cell pathway by Ig-β. Science 272, 411-414 (1996).
86. Meixlsperger, S. et al. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 26, 323-333 (2007).
87. Ohnishi, K. and Melchers, F. The nonimmunoglobulin portion of λ5 mediates cell-auttonomous pre-B cell receptor signaling. Nature Immunol. 4, 849-856 (2003).
88. Bankovich, A. J. et al. Structural insight into pre-B cell receptor function. Science 316, 291-294 (2007).
89. Vettermann, C. et al. A unique role for the lambda5 non-immunoglobulin tail in early B lymphocyte development. J. Immunol. 181, 3232-3242 (2008).
90. Kohler, F. et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 29, 912-921 (2008).
91. Bradl, H., Wittmann, J., Milius, D., Vettermann, C. and Jack, H. M. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate. J. Immunol. 171, 2338-2348 (2003).
92. Gauthier, L., Rossi, B., Roux, F., Termine, E. and Schiff, C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl Acad. Sci. USA 99, 13014-13019 (2002).
93. Espeli, M., Mancini, S. J. C., Breton, C., Poirier, F. and Schiff, C. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 113, 5878-5886 (2009).
94. Mourcin, F. et al. Galectin-1-expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow. Blood 117, 6552-6561 (2011).
95. Keenan, R. A. et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321, 696-699 (2008).
96. Eschbach, C. et al. Efficient generation of B lymphocytes by recognition of self-antigens. Eur. J. Immunol. 41, 2397-2403 (2011).
97. Doughty, C. A. et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107, 4458-4465 (2006).
98. Ward, P. S. and Thompson, C. B. Signaling in control of cell growth and metabolism. Cold Spring Harb. Perspect. Biol. 4, a006783 (2012).
99. Lazorchak, A. S. et al. Sin1-mTORC2 suppresses rag and Il7r gene expression through Akt2 in B cells. Mol. Cell 39, 433-443 (2010).
100. Rathmell, J. C. et al. Akt-directed glucose matabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23, 7315-7328 (2003).
101. Gottlob, K. et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15, 1406-1418 (2001).
102. DeBerardinis, R. J. and Thompson, C. B. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148, 1132-1144 (2012).
103. Powell, D. J. and Delgoffe, G. M. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33, 301-311 (2010).
104. Iritani, B. M. and Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci, USA 1999, 13180-13185 (1999).
105. Grumont, R. J., Strasser, A. and Gerondakis, S. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell 10, 1283-1294 (2002).
106. Dang, C. V. MYC on the path to cancer. Cell 149, 22-35 (2012).
107. Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunol. 9, 405-414 (2008).
108. Sandoval, G. J. et al. Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells. J. Immunol. 190, 2485-2489 (2013).
109. Yasuda, T. et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28, 499-508 (2008).
110. Rolink, A., Winkler, T., Melchers, F. and Andersson, J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J. Exp. Med. 191, 23-31 (2000).
111. Parker, M. J. et al. The pre-B-cell receptor induces silencing of VpreB and λ5 transcription. EMBO J. 24, 3895-3905 (2005).
112. Melchers, F. The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nature Rev. Immunol. 5, 578-584 (2005).
113. Melchers, F. et al. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol. Rev. 175, 33-46 (2000).
114. van Loo, P. F., Dingjan, G. M., Maas, A. and Hendriks, R. W. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity 27, 1-13 (2007).
115. Jumaa, H. et al. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11, 547-554 (1999).
116. Xu, S., Lee, K. G., Huo, J., Kurosaki, T. and Lam, K. P. Combined deficiencies in Bruton tyrosine kinase and phospholipase Cγ2 arrest B-cell development at a pre-BCR+ stage. Blood 109, 3377-3384 (2007).
117. Bai, L. et al. Phospholipase Cγ2 contributes to light-chain gene activation and receptor editing. Mol. Cell. Biol. 27, 5957-5967 (2007).
118. Thompson, E. C. et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26, 335-344 (2007).
119. Heng, T. S., Painter, M. W. and Consortium, I. G. P. The Immunological Genome Project: networks of gene expression in immune cells. Nature Immunol. 9, 1091-1094 (2008).
120. Iritani, B. M., Forbush, K. A., Farrar, M. A. and Perlmutter, R. M. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16, 7019-7031 (1997).
121. Mandal, M. et al. Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid. Proc. Natl Acad. Sci. USA 105, 20840-20845 (2008).
122. Ley, R., Balmanno, K., Hadfield, K., Weston, C. and Cook, S. J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278, 18811-18816 (2003).
123. Um, J. H. et al. Metabolic sensor AMPK directly phosphorylates RAG1 protein and regulates V(D)J recombination. Proc. Natl Acad. Sci. USA 110, 9873-9878 (2013).
124. Park, H. et al. Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 36, 1-13 (2012).
125. Stanhope-Baker, P., Hudson, K., Shaffer, A. L., Constantinescu, A. and Schlissel, M. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85, 887-897 (1996).
126. Young, F. et al. Influnence of immunoglobulin heavy-and light-chain expression on B-cell differentation. Genes Dev. 8, 1043-1057 (1994).
127. Flemming, A., Brummer, T., Reth, M. and Jumaa, H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nature Immunol. 4, 38-43 (2003).
128. Shaw, A. C., Swat, W., Ferrini, R., Davidson, L. and Alt, F. W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189, 123-129 (1999).
129. Shaw, A. C., Swat, W., Davidson, L. and Alt, F. W. Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc. Natl Acad. Sci. USA 96, 2239-2243 (1999).
130. Kee, B. L., Quong, M. W. and Murre, C. E2A proteins: essential regulators at multiple stages of B-cell development. Immunol. Rev. 175, 138-149 (2000).
131. Inlay, M. A., Tian, H., Lin, T. and Xu, Y. Important roles for E protein binding sites within the immunoglobulin k chain intronic enhance in avtivating V-κJ-κ rearrangement. J. Exp. Med. 200, 1205-1211 (2004).
132. Ronanow, W. J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 215-223 (2000).
133. Lazorchak, A., Jones, M. E. and Zhuang, Y. New insights into E-protein function in lymphocyte development. Trends Immunol. 26, 334-338 (2005).
134. Lazorchak, A. S., Schlissel, M. S. and Zhuang, Y. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin κ locus in pre-B cells. Mol. Cell. Biol. 26, 810-821 (2006).
135. Schlissel, M. S. Regulation of activation and recombination of the murine Igκ locus. Immunol. Rev. 200, 215-223 (2004).
136. Beck, K., Peak, M. M., Ota, T., Nemazee, D. and Murre, C. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 206, 2271-2284 (2009).
137. Sakamoto, S. et al. E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus. J. Immunol. 188, 5547-5560 (2012).
138. Lu, R., Kay, L., Lancki, D. W. and Singh, H. IRF-4,8 orchestrate the pre-B to B transition in lymphocyte development. Genes Dev. 17, 1703-1708 (2003).
139. Ma, S., Pathak, S., Trinh, L. and Lu, R. Interferon regulatory factors 7 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B cell receptor and promote cell-cycle withdrawal in pre-B cell development. Blood 111, 1396-1403 (2008).
140. Mandal, M. et al. Epigenetic repression of the Ig-κ locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nature Immunol. 12, 1212-1220 (2011).
141. Xu, C.-R. and Feeney, A. J. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling. J. Immunol. 182, 1362-1369 (2009).
142. Aiba, Y., Kameyama, M., Yamazaki, T., Tedder, T. F. and Kurosaki, T. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 111, 1497-1503 (2008).
143. Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B. I. and Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20, 335-344 (2004).
144. Park, S. Y. et al. Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments. J. Immunol. 190, 1094-1102 (2013).
145. Fleming, H. E. and Paige, C. J. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15, 521-531 (2001).
146. Vosshenrich, C. A., Cumano, A., Muller, W., Di Santo, J. P. and Vieira, P. Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment. Proc. Natl Acad. Sci. USA 101, 11070-11075 (2004).
147. Llorian, M., Stamataki, Z., Hill, S., Turner, M. S. and Martensson, I. L. The PI3K p110δ is required for down-regulation of RAG expression in immature B cells. J. Immunol. 178, 1981-1985 (2007).
148. Schram, B. R. et al. B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements. J. Immunol. 180, 4728-4741 (2008).
149. Tze, L. E. et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol. 3, e82 (2005).
150. Nemazee, D. and Weigert, M. Revising B cell receptors. J. Exp. Med. 191, 1813-1817 (2000).
151. Casellas, R. et al. Contribution of receptor editing to the antibody repertoire. Science 291, 1541-1544 (2001).
152. Casellas, R. et al. Igκ allelic inclusion is a consequence of receptor editing. J. Exp. Med. 204, 153-160 (2007).
153. Buckley, R. H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22, 625-655 (2004).